RVTY vs XGN · P/E 42, rev $1.44B vs rev $37.2M
Revvity Inc. (RVTY) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
RVTY currently screens at market cap $11.94B and trailing P/E 41.9. XGN currently screens at market cap $154.1M.
Not investment advice. Open the RVTY and XGN stock pages for the full models.
Not investment advice.